A Randomized Comparison of Personalized Therapy Mgmt Based On Coronary Atherosclerotic Plaque Vs. Usual Care for Symptomatic Patients With Suspicion of CAD
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Maros Ferencik, MD
Oregon Health and Science University
Principal Investigator - Todd Villines, MD
University of Virginia
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
21 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Cardiology Associates of Mobile
Mobile, Alabama, United States
- Valiance Clinical Research- Huntington Park
Huntington Park, California, United States
- Cardiovascular Institute of San Diego
San Diego, California, United States
- Valiance Clinical Research- Tarzana
Tarzana, California, United States
- Lundquist Institute for Biomedical Innovation at Harbor-Ucla Medical Center
Torrance, California, United States
- Intermountain Health Saint Joseph Hospital
Broomfield, Colorado, United States
- Tampa Cardiovascular Interventions and Research
Tampa, Florida, United States
- Flourish Research
Winter Park, Florida, United States
- Endeavor Health Clinical Operations
Evanston, Illinois, United States
- Mercyone Des Moines Medical Center
West Des Moines, Iowa, United States
- Saint Elizabeth Medical Center
Edgewood, Kentucky, United States
- Tulane University
New Orleans, Louisiana, United States
- Flourish- Bowie
Bowie, Maryland, United States
- St. Louis Heart and Vascular
Bridgeton, Missouri, United States
- Advanced Heart and Vascular Institute of Hunterdon
Flemington, New Jersey, United States
- Capital Cardiology Associates
Albany, New York, United States
- University of Cincinnatti
Cincinnati, Ohio, United States
- Oklahoma Cardiovascular Research Group
Oklahoma City, Oklahoma, United States
- the University of Tennessee Medical Center
Knoxville, Tennessee, United States
- Medical City Fort Worth Hospital
Fort Worth, Texas, United States
- Chippenham and Johnston Willis Hospitals
Richmond, Virginia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 18 Dec 2024
- Primary completion
- 31 Dec 2026
- Completion
- 31 Dec 2026
- Last update posted
- 5 Jun 2026
- Registered enrollment
- 1,000
- Registry id
- NCT06713239
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.